(Q38899711)

7 September 2017

title

Evaluation of chemotherapeutics in a three-dimensional breast cancer model (English)

1 reference

7 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Vicky M. Avery

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Todd B Shelper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

15 March 2015

1 reference

Journal of Cancer Research and Clinical Oncology

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

951-959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-015-1950-1

6 June 2020

exact match

0 references

cites work

Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Three-dimensional cell culture: the missing link in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Engineering tumors: a tissue engineering perspective in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Metrics other than potency reveal systematic variation in responses to cancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Comparing statistical methods for quantifying drug sensitivity based on in vitro dose-response assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Three-dimensional tissue culture models in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Miniaturized three-dimensional cancer model for drug evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Advanced cell culture techniques for cancer drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

A novel model of dormancy for bone metastatic breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Environment-mediated drug resistance: a major contributor to minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Metastatic breast cancer: an updating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Micropatterns of Matrigel for three-dimensional epithelial cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1950-1

Activity of anticancer agents in a three-dimensional cell culture model

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25773123

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00432-015-1950-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773123%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference